HAART Lowers Risk of Secondary Cancers After Kaposi Sarcoma
There has been a significant decline in the risk of secondary cancers after Kaposi sarcoma in the era of highly-active antiretroviral therapy.
Skin Cancer
Patients with Nonmelanoma Skin Cancers Have Higher Levels of Arsenic
Some arsenic species levels are higher in patients with nonmelanoma skin cancer.
UVB-Induced Skin Cancer Prevented by Some Beta Blockers, Carvedilol
Carvedilol, a beta blocker, can protect against the sun-induced cell damage that leads to skin cancer.
Teledermatology Detects Similar Skin Cancer Incidence
Skin cancer incidence is similar for patients evaluated by SAF teledermatology or F2F consultation.
Seborrheic Keratosis Mimicked by Cutaneous Malignancies
3.1% of lesions deemed seborrheic keratoses, were diagnosed as malignancies.
Evaluating Efficacy of Checkpoint Inhibitors in Melanoma
For older patients with metastatic melanoma, it is safe for them to undergo immunotherapy.
For Sun-Damaged Skin, Staged Excision is Recommended
In patients with chronically sun-damaged skin, staged excision reduces the likelihood of recurrence of melanoma.
Comparing Interferon vs Observation After Melanoma Resection
Overall survival over observation among patients with melanoma is not improved by high-dose interferon-a-2b (IFN) given for 4 weeks intravenously.
Genetics and Targetable Mutations for Gynecologic Melanoma
Using precision medicine may be able to target melanomas of the female genital tract that have unique molecular features.
Intermittent Vismodegib Shows Good Activity in Basal Cell Carcinoma
There was good activity among patients with multiple basal cell carcinomas who were treated with two intermittent vismodegib dosing regimens.
-
Loading...
-
Loading...
Next post in Skin Cancer
